The effects of Hedera helix on viral respiratory infections in humans: A rapid review
Field | Value | Language |
dc.contributor.author | Barnes, Larisa AJ | en_AU |
dc.contributor.author | Leach, Matthew | en_AU |
dc.contributor.author | Anheyer, Dennis | en_AU |
dc.contributor.author | Brown, Danielle | en_AU |
dc.contributor.author | Carè, Jenny | en_AU |
dc.contributor.author | Lauche, Romy | en_AU |
dc.contributor.author | Medina, Daen N | en_AU |
dc.contributor.author | Pinder, Tobey-Ann | en_AU |
dc.contributor.author | Bugarcic, Andrea | en_AU |
dc.contributor.author | Steel, Amie | en_AU |
dc.date.accessioned | 2020-05-27 | |
dc.date.available | 2020-08-27 | |
dc.date.issued | 2020 | en_AU |
dc.identifier.uri | https://hdl.handle.net/2123/23201 | |
dc.description.abstract | Based on the evidence identified in this rapid review, Hedera helix preparations and herbal complex preparations including H. helix may be a therapeutic option for treating early symptoms of respiratory tract infections. The best effectiveness for H. helix preparations has been proven for coughing, as an expectorant and to reduce the frequency and intensity of cough. Only weak evidence was found for all other researched symptoms. Both adults and children tolerate H. helix well. Currently, there is insufficient evidence to recommend the use of this supplement in the treatment or prevention of COVID-19. However, the current evidence justifies further research to better understand its applicability in coronavirus infections. | en_AU |
dc.language.iso | en | en_AU |
dc.subject | COVID-19 | en_AU |
dc.subject | Coronavirus | en_AU |
dc.title | The effects of Hedera helix on viral respiratory infections in humans: A rapid review | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.1016/j.aimed.2020.07.012 |
Associated file/s
There are no files associated with this item.
Associated collections